<?xml version="1.0" encoding="UTF-8"?>
<ref id="R56">
 <label>56</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Ost</surname>
    <given-names>P</given-names>
   </string-name>, 
   <string-name>
    <surname>Reynders</surname>
    <given-names>D</given-names>
   </string-name>, 
   <string-name>
    <surname>Decaestecker</surname>
    <given-names>K</given-names>
   </string-name>, 
   <etal>et al</etal>
  </person-group>. 
  <article-title>Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: a prospective, randomized, multicenter phase II trial</article-title>. 
  <source>J Clin Oncol</source>
  <year>2018</year>;
  <volume>36</volume>:
  <fpage>446</fpage>â€“
  <lpage>53</lpage>. 
  <pub-id pub-id-type="doi">10.1200/JCO.2017.75.4853</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/29240541?>
  <pub-id pub-id-type="pmid">29240541</pub-id>
 </mixed-citation>
</ref>
